Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate Nov 30, 2024 21:08 HKT/SGT Read More
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC Nov 30, 2024 20:34 HKT/SGT Read More
LEQEMBI (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea Nov 28, 2024 15:26 HKT/SGT Read More
Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan Nov 26, 2024 14:50 HKT/SGT Read More
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan Nov 20, 2024 10:51 HKT/SGT Read More
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements Nov 20, 2024 09:24 HKT/SGT Read More
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Nov 19, 2024 14:30 HKT/SGT Read More